Table 6.
Failure (clinical or radiographic) based on lesion location
| Study/year/design | Technique | Hips | Lesion location | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| A | B | C1 | C2 | |||||||
| Hips | Failures | Hips | Failures | Hips | Failures | Hips | Failures | |||
| Lieberman et al. [26] (2004) (R) | CD/BMP | 17 | 3 | 0 (0%) | 7 | 1 (14.3%) | ||||
| Nagoya et al. [39] (2004) (R) | VIG | 35 | 17 | 4 (23.5%) | 18 | 15 (83.3%) | ||||
| Onodera et al. [40] (2005) (R) | TTRO | 37 | 19 | 9 (47.4%) | 18 | 6 (33.3%) | ||||
| Atsumi et al. [2] (2006) (R) | PRO | 35 | 11 | 0 (0%) | 20 | 0 (0%) | 4 hips, 2 failures* | |||
| Seyler et al. [46] (2008) (R) | CD/NVG/OP1 | 39 | 8 | 1 (12.5%) | 12 | 5 (41.7%) | 12 | 2 (16.7%) | 7 | 5 (71.4%) |
| Total | 163 | 22 | 1 (4.6%) | 39 | 6 (15.4%) | 48 | 15 (31.2%) | 43 | 26 (60.4%) | |
* Not included in totals; A: ≤ medial 1/3 weightbearing; B: ≤ medial 2/3 weightbearing; C1: > 2/3 not extending to acetabular ridge; C2: > 2/3 extending to acetabular ridge; P = prospective study; R = retrospective study; CD = core decompression; BMP = bone morphogenic protein; VIG = vascularized iliac graft; TTRO = transtrochanteric rotational osteotomy; PRO = posterior rotational osteotomy; NVG/OP-1 = nonvascularized graft enriched with OP-1.